EXHIBIT 16.1 July 14, 2003 Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Dear Sirs: We have read Item 4, included in the Form 8-K Amendment No.2 dated July 14, 2003 of Repro-Med Systems, Inc. as to be filed with the Securities and Exchange Commission. We are in agreement with the Registrant's statements under Item 4. Sincerely, /s/Radin, Glass & Co., LLP Radin, Glass & Co., LLP